Categories
-
Adhesives
1
Amines
53
Amino Acids
159
Analytical Reagents
211
Antibiotics
174
APIs
509
Aroma Chemicals
128
Biochemicals
608
Boronic Acids
2
Buffers
58
Building Blocks
936
Carbohydrates
117
Chiral Compounds
45
Detergents
40
Diagnostic Raw Materials
104
Flavours and Fragrance Materials
77
Fluorinated Products
32
Furans
7
Gases in Solution
39
Grignard Reagents
1
HPLC Reagents
1
Imidazoles
15
Indoles
43
Inorganic Chemicals
124
Ligands
63
Organics
552
Oxazoles
3
Peptide Reagents
46
Phenols
24
Picolines
0
Piperazines
12
Pyrazines
2
Pyridines
46
Pyrimidines
23
Quaternary Ammonium salts
24
Reagents
40
Research Organics & Inorganics
465
Salts
138
Sealing Compounds
0
Sherclin
0
Solvents
63
Stains & Indicators
208
Sugars
56
Testing Standards
2
Uncategorised
0
Water Analysis
4
o-Cresolphthalein Complexone
(20195051 | 2411-89-4)
| CAS: | 2411-89-4 |
|---|---|
| Molecular Formula: | C32H32N2O12 |
| Molecular Weight: | 636.60 |
| Availablility: | In Stock |
|---|---|
| Downloads: | Product Specification |
| 20195051-5g | 5g | £39.80 | |
| Bulk Order | |||
| 20195051-5g | 5g | €59.70 | |
| Bulk Order | |||
| 20195051-5g | 5g | $71.64 | |
| Bulk Order | |||
Specification
Certificate of Analysis
Product Detail
| Product Code | 20195051 | ||||
| Product Name | o-Cresolphthalein Complexone | ||||
| Categories | Ligands Stains & Indicators | ||||
| CAS | 2411-89-4 | ||||
| Molecular Formula | C32H32N2O12 | ||||
| Molecular Weight | 636.60 | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 29322090 EXP 2932209090 IMP |
Product Specification
| Loss on Drying | 7.23% | ||||
| Storage Temperature | +20 ° C | ||||
| Molecular Weight | 636.6 | ||||
| Solubility | Clear purple solution | ||||
| Residue on Ignition | 0.5% max | ||||
| Nitrogen | 4.1 - 4.7% | ||||
| Lambda max | 573nm in 0.1N sodium hydroxide | ||||
| Appearance | White powder | ||||
| Lamda Max | 575(377)nm in 0.1 N sodium hydroxide | ||||
| Carbon | 58 - 63% |
Safety Information
| Pictograms |
|
||||
| Signal word | none | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|